What the analyst said

Bernstein SocGen Group analyst Stacy Rasgon raised the price target on Texas Instruments (NASDAQ: TXN) to $310 (from $290) while maintaining a Market Perform rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

TXN trades at $284. The 17 analysts who set a target in the last 3 months range from $250 to $405, with a median of $330. This $310 target is 6% below the median.

12-month window: day 1 of 365, closes on October 22, 2027.

Track record

This callOpen: TXN has not reached $310 yet. This 12-month target is scored on October 22, 2027.

Firm track recordBernstein: 75% of its 12 targets at least a year old were reached within 12 months (#22 of 28 firms). Accuracy ranking →

Earnings reactionOne of 13 notes after Texas Instruments’s Oct 21 results: 9 of 13 raised targets. See every call →

Bernstein on Texas Instruments

Bernstein price targets on Texas Instruments

2 calls from July 23, 2026 to October 22, 2026. The target went from $290 to $310 (+7%). The rating stayed Hold.

Bernstein targetTXN share price
  1. October 22, 2026 This noteTarget raised from $290 (+7%)Hold$310
  2. July 23, 2026Earliest call shownHold$290
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.